An interventional study of DeepPriorCBCT-V2 and Clinical standard protocol (Full-radiation-dose CBCT) in Cerebrovascular Diseases, Lung and Liver, sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Recruiting at 5 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.
Sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 83 studies in Cerebrovascular Disorders with a site in China — 41 open to participants now, 42 under way, 2 of them phase 3. Cerebrovascular Disorders · China.
Among the 83 studies in Cerebrovascular Disorders with a site in China, this one is the 8th largest by planned enrollment of the 53 interventional ones that give a count, is one of 3 that started in 2026, is one of 32 with no phase, reaches primary completion later than 18 of the 41 other live ones, and was the 82nd registered.
450 studies on the registry are indexed under Cerebrovascular Disorders; 127 are open to participants now.
Browse Cerebrovascular Disorders studies →41 of the 83 studies in Cerebrovascular Disorders with a site in China are open now. Recruiting first, the newest first:
The Second Hospital of Anhui Medical University · Sites in China
Ages 18+
Xuanwu Hospital, Beijing · Sites in China
Ages 18+
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Sites in China
Ages 18+ · Healthy volunteers
Beijing Tiantan Hospital · Sites in China
Ages 18+ · Healthy volunteers
First People's Hospital of Shenyang · Sites in China
Ages 50–80
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 94 Cerebrovascular Disorders studies recruiting now, 54 (57%) set no upper age limit and 12 (13%) stop at 75 or younger; 9 take children under 18; 19 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
83 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 5 · Phase 3 7 · Phase 4 4
First in 2003; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,380 is above the median of 100 across 274 interventional studies indexed under Cerebrovascular Disorders.
Median enrollment 206 across the 53 interventional studies, 900 across the 30 observational. Of the 21 that completed or were terminated, 4 (19%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 83 have an industry lead sponsor. The 10 most frequent:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology is the lead sponsor of 183 studies on the registry; 146 are open to participants now.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology has 2 studies filed under Cerebrovascular Disorders — fewer than ten, so there is no comparison to draw.
11 of the studies in Cerebrovascular Disorders with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07845929Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyClinical Application of a Low-Dose CBCT AI Model | 2026-11-30 |
| NCT06959784China-Japan Friendship HospitalAssessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study) | 2026-12-31 |
| NCT04433455Huashan HospitalInfluencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients | 2026-12-31 |
| NCT06633809Sir Run Run Shaw HospitalTherapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion | 2026-12-31 |
| NCT07927569Qianfoshan HospitalIntegrated PET/MR Assessment of Brain Recovery After Recanalization of Non-Acute Atherosclerotic MCA Occlusion | 2027-01-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 83 studies in Cerebrovascular Disorders with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cone Beam CT (CBCT) is an imaging modality used in interventional digital subtraction angiography (DSA). It produces three-dimensional images via cone-beam X-ray scanning and computer reconstruction. Clinically, CBCT guides puncture for pulmonary and hepatic lesions and evaluates post-intervention outcomes in liver cancer and cerebrovascular diseases. However, CBCT-guided interventions carry high patient radiation exposure; dose reduction often degrades image quality and impairs procedural results. Studies report that each 100 mGy radiation increment elevates cancer risk by 1.96-fold.
Artificial intelligence enables low-dose CBCT. Our prior DeepPriorCBCT model embedded anatomical priors using neural discrete representation learning, reducing thoracic CBCT dose to one-sixth of routine protocols while preserving image quality. We further developed DeepPriorCBCT-V2 using 55 000 pre-reconstruction CBCT datasets covering brain, thorax and abdomen. This multi-organ model maintains image quality at one-sixth standard radiation dose. Nevertheless, its real-world clinical performance remains unvalidated. We therefore designed this prospective multicenter randomized controlled trial to evaluate the clinical applicability of DeepPriorCBCT-V2.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age ≥18 years.
Requires CBCT-guided interventional treatment or surgery (e.g., cerebral angiography, lung puncture , hepatic artery chemoembolization, or percutaneous liver biopsy) and meets operational indications.
Exclusion Criteria:
History of high-dose radiation exams or treatments.
Known allergies or severe adverse reactions to iodine contrast agents or other relevant medications.
Pregnant or breastfeeding women.
Severe comorbidities or chronic diseases (e.g., severe diabetes, renal insufficiency).
Severe mental illness or cognitive impairment preventing understanding of the study procedures or providing .
⑥ Participants are not suitable for the trial per investigator's opinion.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Biopsy and archival tissue
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients underwent interventional procedures guided by CBCT images reconstructed via the DeepPriorCBCT-V2 model from low-radiation-dose scans (1/6 of the conventional dose for the thorax and abdomen, and 1/5 for the brain).
Other: DeepPriorCBCT-V2
Patients underwent interventional procedures guided by CBCT images reconstructed via clinical standard protocol (full-radiation-dose).
Device: Clinical standard protocol (Full-radiation-dose CBCT)
Compared with conventional CBCT-guided interventional procedures and previously reported low-dose CBCT studies, the intervention adopted in the present study has several distinct advantages. First, most existing low-dose CBCT protocols only reduce radiation for a single anatomical region, mainly the thorax, while our DeepPriorCBCT-V2 model achieves stable low-dose reconstruction for the brain, thorax, and abdomen simultaneously, with radiation reduced to 1/6 of the standard clinical level for the thorax and abdomen and 1/5 for the brain. Second, unlike general noise-reduction algorithms used in previous studies, our model embeds anatomical prior information through neural discrete representation learning, which ensures consistent and reliable image quality at extremely low radiation doses without sacrificing intraoperative guidance accuracy. Third, this study is the first prospective multicenter randomized controlled trial to systematically verify the clinical feasibility of multi-orga
Interventional procedures were performed under the guidance of clinical standard protocol (Full-radiation-dose CBCT).
Radiation dose
Air Kerma (AK) refers to the sum of the initial kinetic energies transferred from uncharged ionizing radiation (such as X-ray photons) to charged particles in air, divided by the mass of air at that location.
Time frame: Through study completion, an average of 5 months.
Operation time
The time from the initiation to the completion of the interventional procedure.
Time frame: Through study completion, an average of 5 months.
Intraoperative complications.
Procedure-related intraprocedural complications.
Time frame: Through study completion, an average of 5 months.
Post operative complications
Procedure-related complications within 7 days after the interventional procedure.
Time frame: Through study completion, an average of 5 months.
Subjective scoring
Scoring of reconstructed CBCT images was performed by radiologists and interventional physicians using a 5-point Likert scale. The scale was defined as: 1 = very poor image quality; lesions cannot be assessed and the procedure cannot be guided; 2 = poor image quality; lesion assessment and procedure guidance are difficult; 3 = moderate image quality; lesion assessment is relatively difficult, but procedure guidance is feasible; 4 = good image quality; lesions can be assessed and procedure guidance is achievable; 5 = excellent image quality; lesion assessment is not compromised at all and procedure guidance is fully supported.
Time frame: Through study completion, an average of 5 months.
Plan to share: No
No publications or documents are linked to this record.
Started Aug 2026 (actual). Primary completion is estimated for Nov 2026, 3 months after the start.
Of 96 non-industry interventional studies with no phase under Cerebrovascular Disorders, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 68. This study's planned 3 months is below that.
Counting every sponsor, half of 111 studies reached it within 30 months; a quarter within 14 and three quarters within 68.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology →